Next |
home / stock / pbla / pbla message board
Subject | By | Source | When |
---|---|---|---|
$PBLA in the news following $7 price target: | JDCruz | investorshub | 04/28/2023 5:36:13 PM |
$PBLA Price gaining last trade up | TheFinalCD | investorshub | 04/27/2023 6:54:50 PM |
Long and strong lets hope im right | molee | investorshub | 04/27/2023 5:40:48 PM |
Oh , I can relate , as I | molee | investorshub | 04/27/2023 5:19:45 AM |
Can you imagine how the shareholders feel? IMHO | subslover | investorshub | 04/26/2023 7:06:14 PM |
$PBLA just had a 1:40 stock split Jan. | molee | investorshub | 04/26/2023 7:02:14 PM |
Here is the problem and it will be | subslover | investorshub | 04/26/2023 6:51:21 PM |
I believe something is brewing. It's going up | SriMaharaj | investorshub | 04/26/2023 5:59:50 PM |
$PBLA .49 AGAIN | TheFinalCD | investorshub | 04/26/2023 4:13:49 PM |
$PBLA: No PR's, etc., that I can find either. | Invest-in-America | investorshub | 04/26/2023 1:35:20 PM |
.78 https://www.benzinga.com/news/23/04/32005454/hc-wainwright-co-initiates-coverage-on-panbela-ther | TheFinalCD | investorshub | 04/26/2023 1:32:22 PM |
HC Wainwright initiated coverage with buy recommendation $7 | James salmon | investorshub | 04/26/2023 1:30:23 PM |
nope just tech move | TheFinalCD | investorshub | 04/26/2023 1:19:41 PM |
No News? | subslover | investorshub | 04/26/2023 12:53:24 PM |
$PBLA .73 | TheFinalCD | investorshub | 04/26/2023 12:43:32 PM |
Damn | Awl416 | investorshub | 04/26/2023 12:39:17 PM |
short squeeze signal | molee | investorshub | 04/26/2023 11:57:28 AM |
$PBLA .49 | TheFinalCD | investorshub | 04/26/2023 11:27:21 AM |
$PBLA news out | molee | investorshub | 04/26/2023 8:27:20 AM |
$PBLA Looks pretty positive | Backstabbed | investorshub | 04/25/2023 11:29:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
MINNEAPOLIS, April 22, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that the interim data analysis for its ...
MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that its common stock has been approved...
MINNEAPOLIS, March 26, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the...